Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-12-20

Clinical Trial Update: A Study to Evaluate the Efficacy of MEDI7510 in Older Adults [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating MEDI7510 for Respiratory Syncytial Virus in older adults was terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MEDI7510

Snippet

Sponsor: MedImmune LLC | Conditions: Respiratory Syncytial Virus | Phase 2 | Status: TERMINATED | Results posted: 2017-12-20